AGP Executive Report
Last update: 8 hours agoMedical Cannabis in Pregnancy: UAMS researchers published a population-level look at how pregnant Arkansans use medical cannabis, analyzing 72,992 pregnancies (2019–2022) and finding 1.62% involved medical cannabis purchases; about two-thirds kept buying before and during pregnancy, while one-third started during pregnancy. Public Health Policy: New York City’s Mamdani administration made permanent a syringe redemption program that pays 20 cents per used syringe, keeping a $3M budget line and extending a contract with a nonprofit that runs eight drop sites. Forensics & Safety Tech: NIST expanded its mass-spectra “chemical fingerprints” library (Standard Reference Database 1A), updating its tool for identifying unknown substances across food, drugs, cosmetics, the environment, and more. Drug Enforcement & Courts: A UK case in Birmingham involved a cannabis-smoking mother who threatened a school with a bomb hoax; she avoided jail with a suspended sentence, while other court items this week continued to mix cannabis with broader criminal charges. CBD/Medical Market Access: Spain’s Curaleaf was reported as the first to supply medical cannabis under a new law, signaling continued expansion of regulated access.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
